-
CureVac Expands Late-stage Trials of COVID Vax Candidate
contractpharma
March 23, 2021
CureVac N.V. plans to expand and further specify the protocols of its ongoing late-stage clinical trials with its COVID-19 vaccine candidate, CVnCoV.
-
WHO statement on AstraZeneca COVID-19 vaccine safety signals
worldpharmanews
March 22, 2021
Some countries in the European Union have temporarily suspended use of the AstraZeneca COVID-19 vaccine as a precautionary measure based on reports of rare blood coagulation disorders in persons who had received the vaccine.
-
Bharat Biotech announces Phase 3 results of COVAXIN®: India's first COVID-19 vaccine demonstrates interim clinical efficacy of 81%
worldpharmanews
March 22, 2021
Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, announced the first interim analysis of its BBV152 (COVAXIN®).
-
EMA clears use of COVID-19 Vaccine AstraZeneca
europeanpharmaceuticalreview
March 22, 2021
The EMA’s drug safety committee concluded that the vaccine is not associated with an increased risk of thromboembolic events and that its benefits still outweigh its risks.
-
CanSino’s Covid-19 vaccine receives approval in Hungary for emergency use
pharmaceutical-technology
March 22, 2021
The Hungarian National Institute of Pharmacy and Nutrition has granted approval for the emergency use of Chinese company CanSino Biologics’ Covid-19 vaccine.
-
8-10 months protection possible with COVID-19 vaccine: AIIMS director
expresspharma
March 22, 2021
He said the biggest reason for the surge in cases is that people feel the pandemic is over and they are not following COVID-appropriate behaviour.
-
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate
worldpharmanews
March 19, 2021
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, announced the start of the Phase 1/2 clinical trial for MRT5500, an mRNA vaccine candidate against SARS-CoV-2 ...
-
Merck adds assembly production unit in France for Covid-19 vaccines
pharmaceutical-technology
March 19, 2021
Merck is adding a €25m, single-use assembly production unit at its Life Science Center (LSC) in Molsheim, France, to manufacture Covid-19 vaccines and other therapies.
-
EMA review concludes AstraZeneca Covid-19 vaccine is “safe and effective”
pharmaceutical-technology
March 19, 2021
The European Medicines Agency (EMA) has concluded that the AstraZeneca/Oxford University Covid-19 vaccine is “safe and effective” after an investigation into a potential link between the vaccine and blood clots in a small number of patients.
-
Philippines gives approval to Sputnik V Covid-19 vaccine for emergency use
pharmaceutical-technology
March 19, 2021
The Food and Drug Administration of the Philippines has given approval to Sputnik V Covid-19 vaccine for emergency use, as the country struggles with spike in infections.